Intuitive Surgical (ISRG) Capital Expenditures (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Capital Expenditures came in at -$34.5 million in Q2 2026, up 17.46% year-on-year from -$29.4 million in Q2 2025, and down 133.4% quarter-over-quarter from $103.3 million in Q1 2026.
Intuitive Surgical (ISRG) Capital Expenditures (2009 - 2026) Analysis & Trends
Intuitive Surgical's Capital Expenditures history runs 18 years deep, the most recent figure standing at -$34.5 million for Q2 2026.
- On a quarterly basis, Capital Expenditures rose 17.46% year-over-year to -$34.5 million in Q2 2026; TTM through Jun 2026 was $533.8 million, a 15.9% decrease from a year earlier, with the FY2025 full-year figure at $539.8 million, down 51.42% from the prior year.
- Capital Expenditures eased to -$34.5 million in Q2 2026 per ISRG's latest filing, from $103.3 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $435.5 million in Q4 2023 and bottomed at -$41.8 million in Q2 2025.
- The 5-year median for Capital Expenditures is $173.7 million (2022), against an average of $184.2 million.
- Across the five-year window, Capital Expenditures soared 212.86% in 2023 and slumped 113.51% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $139.2 million in 2022, then surged by 212.86% to $435.5 million in 2023, then slipped by 28.36% to $312.0 million in 2024, then sank by 47.92% to $162.5 million in 2025, then slumped by 121.23% to -$34.5 million in 2026.
- Per Business Quant, the three latest ISRG Capital Expenditures figures stand at -$34.5 million (Q2 2026), $103.3 million (Q1 2026), and $162.5 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 137.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.50 Mn |
| Jun 30, 2026 | -34.50 Mn |
| Mar 31, 2026 | 103.30 Mn |
| Mar 31, 2026 | 103.30 Mn |
| Dec 31, 2025 | 162.50 Mn |
| Dec 31, 2025 | 162.50 Mn |
| Sep 30, 2025 | 302.50 Mn |
| Sep 30, 2025 | 302.50 Mn |
| Jun 30, 2025 | -41.80 Mn |
| Jun 30, 2025 | -41.80 Mn |
| Mar 31, 2025 | 116.60 Mn |
| Mar 31, 2025 | 116.60 Mn |
| Dec 31, 2024 | 312.00 Mn |
| Dec 31, 2024 | 312.00 Mn |
| Sep 30, 2024 | 247.90 Mn |
| Sep 30, 2024 | 247.90 Mn |
| Jun 30, 2024 | 309.40 Mn |
| Jun 30, 2024 | 309.40 Mn |
| Mar 31, 2024 | 241.90 Mn |
| Mar 31, 2024 | 241.90 Mn |